Parameter | Liver fibrosis patient group (n = 55) | Kruskal-Wallis test | |||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Subgroup І F0-F1 | Subgroup II F2 | Subgroup III F3–F4 | H | p value | |||||||
n. | Median | Q1–Q3 | n. | Median | Q1–Q3 | n. | Median | Q1–Q3 | |||
Age (years) | 16 | 32 | 28–47.25 | 12 | 37.5 | 32–47.5 | 22 | 52.5 | 43.75–57.5 | 12.522 | 0.002 |
Weight (kg) | 18 | 73.5 | 68–78.25 | 13 | 75 | 67.5–86.5 | 24 | 70 | 66.5–84.5 | 0.273 | 0.873 |
AST (IU/L) | 18 | 28 | 21–36.25 | 13 | 25 | 19–43 | 24 | 50.5 | 8.75–72.5 | 20.873 | 0 |
ALT (IU/L) | 18 | 27 | 20.25–43.5 | 13 | 35 | 21.5–48 | 24 | 47 | 35.5–64.25 | 9.367 | 0.009 |
T. bilirubin (mg/dl) | 18 | 0.65 | 0.475–0.8 | 13 | 0.6 | 0.35–0.8 | 24 | 1 | 0.8–1.75 | 16.122 | 0 |
D. bilirubin (mg/dl) | 18 | 0.2 | 0.1–0.2 | 13 | 0.2 | 0.1–0.3 | 24 | 0.3 | 0.2–0.7 | 13.276 | 0.001 |
Albumin (g/L) | 17 | 4.1 | 3.95–4.45 | 13 | 4.2 | 4–4.5 | 24 | 3.55 | 3.2–4.1 | 14.857 | 0.001 |
Platelets (10^3/ul) | 18 | 232 | 188.25–256 | 13 | 256 | 219–295.5 | 24 | 135 | 91–223.75 | 15.835 | 0 |
INR | 18 | 1 | 0.987–1.025 | 13 | 1 | 1–1.1 | 23 | 1.1 | 1–1.3 | 10.895 | 0.004 |
AFP (IU/ml) | 9 | 2.5 | 1.2–5.45 | 11 | 2.9 | 1.9–4.5 | 23 | 9.2 | 2.9–13.6 | 9.89 | 0.007 |
GDF-15 (ng/L) | 18 | 340 | 220–500 | 13 | 500 | 405–510 | 24 | 415 | 335–587.5 | 5.185 | 0.075 |